Patent · US Active

Method for treating a side effect caused by BCG perfusion therapy for bladder cancer

US11793851B2 · kind B2 · utility

0Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 3, 2020
Grant dateOct 24, 2023
Priority date
Expiry dateJun 11, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method for treating a side effect caused by bacillus Calmette-Guérin (BCG) perfusion therapy for bladder cancer. The method includes: administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising Gentiana scabra, Scutellariae Radix, Gardeniae Fructus, Angelicae Sinensis Radix, Rehmanniae radix, Akebiae Caulis, Bupleurum chinense, Plantaginis Semen, Atractylodes lancea, Rhizoma alismatis, and Glycyrrhiza uralensis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.